🗨️ "#ACC26 was a hub of knowledge, innovation, and professional growth." Read “An ACPC Perspective From a First-Time Attendee” & relive the #ACC26 experience. ➡️ https://bit.ly/48L1bMU #ACCACPC

#ACCHealthEquity in action! The ACC’s New Orleans Health Fair in March welcomed more than 300 community members for free 🫀 health screenings and interactive education sessions. Read more in #CardiologyMag 👉 https://bit.ly/4eJN7r5 #hearthealth #CardioSky

ICYMI: The community burden of sudden cardiac death was the topic of two separate studies presented at #HRS2026 and simultaneously published in #JACC. Get full details here ➡️ https://bit.ly/4cGwgmh #cvEP #CardioSky @jaccjournals.bsky.social

Join #ACCInnovation Section's discussion on opportunistic detection of subclinical #ASCVD using #AI. Questions? Get them answered by the panel of experts as they explore the integration of AI algorithms in analyzing routine imaging studies. Learn more ➕ register ➡️ https://bit.ly/4t0xKOd #cardiosky

📣 Submit your most compelling abstracts & clinical cases for possible presentation at #ACCLATAM 2026, 17-19 Sept., in Medellín, Colombia. Top submissions may even earn a spot at #ACC27-#WCCardio. 🌍 Deadline 🔜 Tuesday, May 12. 🔗 https://bit.ly/4cN0zcC #ACCIntl

Have you submitted your application for ACC's Leadership Accelerator program yet? Apps are due Tuesday, May 19. Details ⬇️ ✅ Define and strengthen your leadership skills 🤝 Network with other #ACCEarlyCareer peers and mentors 🔗 https://bit.ly/4l9z2TM #ACCLeadership #CardioSky

📣 Call For Nominations: Douglas P. Zipes Distinguished Young Scientist Award The 🏆 recognizes young physician scientists who have made outstanding contributions to the field of #CVD. Help your trainees gain the recognition they deserve. Learn more: https://bit.ly/4sz2iGQ #CardioSky

This #WorldImmunizationWeek, make prevention part of every visit with your cardiology patients. Download our free pocket guide for adult immunization conversations in cardiovascular care👇 🔗 https://bit.ly/4cNfJhn #CardioSky

Join #ACCEP Section next week for a review of the 2026 HRS Expert Consensus Statement Update on CV Implantable Electronic Device Lead Management and Extraction. Register now to review highlights with experts ➡️ https://bit.ly/4vQdvp4 #EPeeps #cvEP #CardioSky

🌎 💉 This #WorldImmunizationWeek, explore how preventing infectious diseases can also reduce CV risk & improve long-term outcomes. 🔗 Learn more with ACC’s FREE #NCDAcademy course: https://bit.ly/4cvHg5E #NCDs #cvPrev

🎙️ ACC Practice Made Perfect: Experts discuss the evolving challenges service lines face, share practical considerations for improving day-to-day operations, and reflect on how dyad leaders can work together to guide meaningful change. 🎧 Tune in: https://bit.ly/4t0KtR3 #ACCCVT

Applications Open 📢 The College is accepting applications for Vice President and 2️⃣ Trustee positions. Help shape ACC's direction and impact on the field of #cardiology! 📣 Intent to Submit Due: May 22 📝 Full Application Due: June 15 🔗 https://bit.ly/4czbO7Z #ACCLeadership #CardioSky

PRO-TAVI: Older patients w/ #cvCAD for whom #PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred. Learn more about this & other #ACC26 Structural Intervention Trials, including PROTECT H2H & SURViV. ➡️ https://bit.ly/4cv5iPH #ACCIC #CardioSky

🔦 We’re spotlighting the importance of #healthequity in CV care for #NationalMinorityHealthMonth. Improving #hearthealth for all means meeting people where they are, and the ACC’s New Orleans Health Fair is 1️⃣ example of how community drives equity. #ACCHealthEquity ➡️ https://bit.ly/41DHqmz #NMHM26

The cardiology community has lost a giant. We honor the extraordinary legacy of Eugene Braunwald, MD, MACC, a visionary leader and pioneer whose outstanding contributions shaped the foundation of cardiovascular medicine as we know it today. Read more: https://bit.ly/41NEXGp

🆕 ACC/AHA/HRS Advanced Training Statement outlines the core competencies required of subspecialists in CCEP to optimally diagnosis & treat patients w/ cardiac arrhythmias & conduction disturbances, updating the 2015 guidance. More: https://bit.ly/4crpthh #JACC #CardioSky @jaccjournals.bsky.social

Are you an #ACCEarlyCareer ready to lead? 💼 Apply to be part of the #ACCLeadership Accelerator Class of 2027! Participants like Dr. Edward Chu gain high-impact training in leadership, communication, executive presence ➕ more. Apply by May 19 👉 https://bit.ly/4l9z2TM

It's #EarthDay! Did you know that #AirPollution is linked to ⬆️ risk of heart attack, #diabetes, #stroke, #heartfailure & more. Use #CardioSmart’s "Air Pollution and Your Heart" infographic to support prevention conversations with patients: https://bit.ly/4dRrxAr #CardioSky #EarthDay2026 #cvPrev

#ACCAsia: In adults with #CVD in South Korea, the rates of awareness & treatment of key CV risk factors were higher in women than in men, but they had lower rates of risk factor control, particularly for hypertension & hypercholesterolemia. Read more: https://bit.ly/48as10S #CardioSky #MedSky

In honor of #NationalMinorityHealthMonth, we’re championing inclusive clinical research. Representation in studies helps ensure treatments work across all communities and leads to better, safer care for everyone. Learn more from #CardioSmart 👉 https://bit.ly/4sz0YUl #ACCHealthEquity #NMHM26

Application Open❗ Apply for the ACC’s Leadership Accelerator Class of 2027 today and join a growing program designed to help #ACCEarlyCareer build core leadership skills and competencies. Learn more and apply by May 19 👉 https://bit.ly/4l9z2TM #ACCLeadership

"We cannot transform cardiovascular care in siloes. It will take all of us, working together, ..." writes #ACCPresident Roxana Mehran, MD, FACC, in a recent #ACCLeadership Update. Read more for reflections ➕ highlights from the March BOT Meeting at #ACC26 ➡️ https://bit.ly/4teguGe #ACCBOT

The joint EAPC/ESC and ACC Clinical Consensus Statement provides an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes. Read the journal scan for more 👉 https://bit.ly/4vnexZx #SportsCardio #JACC #CardioSky

🆕 #JACC Spotlight Issue highlights key guideline recommendations for acute #PulmonaryEmbolism through a patient-centered journey – from risk factors to long-term management, while also identifying areas for future clarification and updates. Read more: https://bit.ly/4cAZoME #CardioSky

Outpatient management of isolated left-to-right shunt lesions in pediatric patients with #CHD is the focus of a 🆕 2026 ACC Concise Clinical Guidance report. Learn more: https://bit.ly/4sTenY2 #CardioSky #MedSky

📺 Panel Discussion from #ACC26: Dive into the 🆕 Dyslipidemia Guideline and VESALIUS-CV Late-Breaking Clinical Trial with Drs. Fred M. Kusumoto, R. Scott Wright and Eugene Yang. Watch now on #ACCAnywhere TV! ➡️ https://bit.ly/4c2CRXU

#ACC26 findings aren't just resonating within the cardiology community – they're reaching patients and the wider public too. Here's a look at some of the standout studies making headlines in major consumer news outlets ➡️ https://bit.ly/4seoOEz #CardiologyMag

The ACC joins with the @worldheart.org to bring together thousands of cardiovascular professionals from across the globe. 🌏 📆 Mark your calendar for #ACC27 Together With WCC, taking place April 10 – 12, 2027 in Houston, TX! We hope to see you there! 🔗 https://bit.ly/4m4y9xj

📣 #ACC26 Attendees: Catch up on sessions you missed with access to 200+ sessions from ACC.26 on demand. Your ACC.26 registration includes a three-month FREE trial to #ACCAnywhere. Activate your ACC Anywhere subscription and continue your learning ➡️ https://bit.ly/3NSOkkM

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ACC26, such as STEMI-DTU, ORBITA-CTO, & more! 📽️: youtu.be/xvLFmv2-Et0?... #JACC #CardioSky @accintouch.bsky.social

👏 Congratulations to ACC Vice President Hani K. Najm, MD, MSc, FACC, and all our 🆕 esteemed ACC leaders! 🔗 More about the College's new officers and trustees who took office following Convocation at #ACC26: https://bit.ly/3NDAOS1 #ACCLeadership #CardioSky

Please join us in congratulating new #ACCPresident Roxana Mehran, MD, FACC! Walking the #ACC26 stage, she shared, “Transforming cardiovascular care for all cannot happen in silos. It requires collaboration.” 💬 https://bit.ly/4m2crKq #ACCLeadership

#ACC26 we see you and your blue! 💙 🩵 💙 From the pickleball court 🏓 to the stages 🎤 and lounges 🛋️, so many of you are showing your ACC pride on the final day of the ACC Annual Scientific Session in New Orleans!

FUND-HF pilot trial at #ACC26: Providing financial support early after hospital discharge to economically vulnerable patients with #heartfailure with reduced ejection fraction is feasible and significantly improved adherence to prescribed medications. 🔗 https://bit.ly/47rgf1O

#ACC26 DKCRUSH VIII: When using the two-stent DK crush technique for #PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated w/ a greater reduction in target vessel failure compared to angiography-guided PCI. More: 🔗 https://bit.ly/47w3WRR #CardioSky #JACC

A noninvasive device used to monitor early fluid accumulation in the lungs of patients with #HFpEF substantially reduced HF hospitalizations and mortality. Check out the results from the IMPEDANCE-HFPEF trial presented during #ACC26 ➡️ https://bit.ly/47refXm #CardioSky

#ACC26 CORALreef AddOn: The novel PCSK9 oral inhibitor enlicitide effectively lowered LDL-C in adults already being treated with statins, demonstrating a potential role as an add-on option for patients not meeting LDL-C goals. Learn more: https://bit.ly/4uW7VRL #JACC #CardioSky

A new system that uses #AI to assess CV risk based on retinal images demonstrated a strong correlation with standard cardiovascular risk assessment, according to research presented during an Investigative Horizons session at #ACC26. Find out more: https://bit.ly/4bU3Swl #CardioSky

Results of IVUS-CHIP and OPTIMAL: When compared with angiography-guided #PCI, IVUS-guided PCI was found to be not superior in patients with 👇 ❇️ Complex coronary arteries ➡️ IVUS-CHIP ❇️ Unprotected LM-CAD ➡️ OPTIMAL More on these #ACC26 LBCT trials: https://bit.ly/3Q7OZiK #CardioSky

#ACC26 SirPAD: For patients with symptomatic infrainguinal artery disease, angioplasty with a sirolimus-coated balloon, compared with an uncoated balloon, reduced major adverse limb events at one year. Read the full results: https://bit.ly/47Rqj4r #CardioSky

Essence-CTA: Does Olezarsen Reduce Noncalcified Coronary Plaque Volume? Check out the results of the 🆕 #ACC26 late-breaking clinical trial: https://bit.ly/4tc0UKH #cvLipids #CardioSky

Dig-RHD: Digoxin lowered the risk of death or new-onset or worsening #heartfailure compared with placebo in patients with rheumatic heart disease (RHD). #ACC26 See the full results ➡️ https://bit.ly/4lYK9Al #CardioSky

SMART-DECISION: Discontinuing beta-blocker therapy was found to be noninferior to continuing the therapy among stable, low-risk patients who took it for at least one year following a #cvMI. Get the latest insights from the #ACC26 LBCT: https://bit.ly/4bPRayM #CardioSky

#ACC26 THRIVE: A culturally tailored food-is-medicine intervention significantly reduced SBP in Black and Hispanic adults with hypertension, compared with those who received an equivalent amount of fresh produce without the additional supports. Read more: https://bit.ly/4dQA8TF #CardioSky

🎉 Welcome to the final day of #ACC26! What’s Brewing today? ☕ ✅ LBCTs ✅ Personalized Skills Zone ✅ Guideline Goldmine Gameshow ✅ Convocation & Closing Ceremony ➕ More! Three days of learning. One final day to go all in. Don't miss a beat! 🫀

TRI-FR at #ACC26: T-TEER in addition to standard-of-care medical therapy reduced the risk of death, #cvMI, stroke and hospitalization for #heartfailure compared with standard-of-care alone in patients with severe symptomatic #vhdTR. Learn more: https://bit.ly/3PCWUVm #CardioSky

PROTECT H2H: Emboliner vs. Sentinel Embolic Protection Devices in #TAVR Explore the findings from the trial unveiled during a Late-Breaking Clinical Trial session at #ACC26: https://bit.ly/4sFQK5r #CardioSky

🔓 We’re working to unlock a $25,000 matching gift during #ACC26. Every donation gets us closer. Help us: ✔️ Empower future leaders ✔️ Advance science ✔️ Fund Travel Grants for Emerging CV Professionals Give today. Double your impact. https://bit.ly/4sZvLKl #ACCGivesBack

Older patients with #cvCAD for whom #PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study presented in a Late-Breaking Clinical Trial session at #ACC26. Learn more: https://bit.ly/4sFz75F

Results from the SURVIV study presented during a Late-Breaking Clinical Trial session at #ACC26: mViV vs. rMVR For Mitral Bioprosthetic Valve Dysfunction Get full details: https://bit.ly/3Nv1yEc #CardioSky